search
Back to results

Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects

Primary Purpose

Birth Defects

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Standard tertiary interventions of birth defects
Additional preconception health care
Additional health care procedures during and after pregnancy
Sponsored by
Children's Hospital of Fudan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Birth Defects focused on measuring Birth Defects, periconception, randomized controlled trial, folate

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Females and their husbands attend pre-pregnancy physical examinations from Minhang distrit and Songjiang distrit in Shanghai.
  • Couples who have planned to be pregnant within a year
  • Women are between 18 and 45 years old

Exclusion Criteria:

-

Sites / Locations

  • Children Hospital of Fudan UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Interventional

Control

Arm Description

Standard tertiary interventions of birth defects; Additional preconception health care; Additional health care procedures during and after pregnancy.

Standard tertiary interventions of birth defects; Additional health care procedures during and after pregnancy.

Outcomes

Primary Outcome Measures

Incidence of total fetal birth defects found during the second trimester, still birth, and neontal birth defects identified after delivery
This is a composite outcome: the total number of fetus defects detected by Down's syndrome screenings, NT examinations and Ultrasound image examinations during the second trimester, stillbirth, and the number of birth defects after delivery diagnosed by clinical team. (Defects are classified in consistent with our birth defect monitoring policy, which have 24 types of defects: Anencephalus; Spina bifida; Encephalocele; Congenital Hydrocephalus; Cleft Palate; Cleft Lip; Cleft Lip with Cleft Palate; Microtia (including Anotia); Deformity of external ear(s) (except Microtia and Anotia); Esophageal atresia or stenosis; Anorectal atresia (including Congenital Anorectal Malformations); Hypospadia; Ectopocystis; Pes Equinovarus; Polydactylism; Syndactylia; Limb shortening; Congenital Diaphragmatic Hernia; Pcromphalus; Celoschisis; Conjoined Twins; Trisomy 21 syndrome; Congenital heart disease; Others. )

Secondary Outcome Measures

Incidence rate of total abortion because of the affected congenital defects
Reasons of abortion are recorded
Incidence of death or severe organ dysfunctions
Severe organ dysfunctions were defined based on specialty clinical examinaitons
Extra medical cost that relates to affecting any birth defects during pregnancy and after birth
Additional medical cost that exceeds normal pregnancies and children within one year old
incidence of congenital heart defect
congenital heart defects diagnosed during pregnancy (ultrasound) and after birth( Echocardiography). (Definition see Zhao et al. Lancet 2014)
Total pregnancy loss
artificial abortions without any medical reasons were exluded

Full Information

First Posted
October 24, 2018
Last Updated
August 29, 2023
Sponsor
Children's Hospital of Fudan University
Collaborators
Minhang Maternal and Children Health Hospital, Songjiang Maternal and Children Health Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03725878
Brief Title
Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects
Official Title
Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects : a Cluster Randomisation Intervention Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 31, 2018 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's Hospital of Fudan University
Collaborators
Minhang Maternal and Children Health Hospital, Songjiang Maternal and Children Health Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project is a single blind cluster randomized controlled trial with a purpose of assessing the effectiveness of a comprehensive tertiary interventions (before pregnancy, during pregnancy and after delivery) on the incidence and the clinical outcomes of birth defects in a preparing-for-pregancy population in Shanghai. The preconception intervention is focused on identifying individuals whose red blood cell folate level is below recommended level for preventing neural tube defects (400ng/ml) or with elevated homocysteine level (over th 80th percentiles, 6.8 µmol/L) , and modifying their folate deficiency status to normal before pregnancy.
Detailed Description
According to World health Organization (WHO), approximately 3.2 million children are born with birth defect(s) worldwide and the incidence of birth defects in China is 5.6%. Birth defects are the main cause of fetal death, infant mortality and morbidity, and long-term disability. Congenital heart defects, oral clefts, hydrocephalus, neural tube defects and mental retardation are most common birth defects in China. Though the etiology of birth defects is still unknow, many studies indicated that maternal key nutrition factors, especially maternal folic acid status, during periconception played an important role in organogenesis, reducing the incidence of neural tube defects, congenital heart diseases and some other birth defects. Our project is a single-blind, cluster randomized controlled trial that aim at evaluating whether hospital-based tertiary intervention approaches reduce the incidence of birth defects (compound primary outcomes, including neural tube defects, congenital heart defects, cleft lips and palates, hydrocephalus, alimentary tract malformations or urological deformities) that identified at middle of gestation via ultrasound or clinical observation at birth. Every couple attending premarital check or preconception physical examination from Minhang and Songjiang district in Shanghai will be recruited. Recruited couples are to draw blood samples and invite to complete questionnaires that collecting informations on diet supplementation. Comprehensive interventions before conception are based on serum folate, red blood cell folate, homocysteine, vitamin B12 and fasting glycemic and lipids profiles. Single nucleotide polymorphisms related to folate and homocysteine matalism pathway will be genotyped in participants with sufficient intake of folic acid but unknown deficiency of the nutrients. Venous blood of pregnant women and questionnaires about the supplementation of key nutrients at the first antenatal visit are also obtained. NT examination, Down's screening, and ultrasound examination results are collected during the second trimester (15-24 gestational week), then routine prenatal genetic counseling, assessment, and diagnosis are provided according to the local policy to those pregnant women with positive screen results indicating high risk of fatal birth defects. Newborns with above mentioned birth defects are provided green channel to clinical specialty team for further diagnosis, surgical correction and rehabilitation guidance. Clinical follow up will be conducted till 6-month old for the prognosis of treatment. The current project will provide evidence on the necessity and effectiveness of preconception intervention focusing on sufficient folate nutrition levels in prevention of birth defects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Birth Defects
Keywords
Birth Defects, periconception, randomized controlled trial, folate

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
cluster rondomization with average cluster size =100 pregnancies.
Masking
Participant
Masking Description
This is a single-blind randomized controlled trial, participants are blinded from their preconceptional folate nutrition status.
Allocation
Randomized
Enrollment
2200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Interventional
Arm Type
Experimental
Arm Description
Standard tertiary interventions of birth defects; Additional preconception health care; Additional health care procedures during and after pregnancy.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Standard tertiary interventions of birth defects; Additional health care procedures during and after pregnancy.
Intervention Type
Procedure
Intervention Name(s)
Standard tertiary interventions of birth defects
Other Intervention Name(s)
Routine preconception and pregnant health cares
Intervention Description
Couples eligible for reproductive policy are entitled to routine health cares including general health cares (health education, medical history inquiry, physical examinations, consulting guidance and pregnancy outcome follow-up) and medical examinations (laboratory examinations, virus screenings and image examinations). But nutrients status are not included in these examinations, such as folate, vitamin B12, and macroelements, et al. Regular antenatal cares are required, such as deformity screening by ultrasound. Routine neonatal screenings are conducted to diagnose infant with birth defect timely.
Intervention Type
Procedure
Intervention Name(s)
Additional preconception health care
Other Intervention Name(s)
Individualized guide for folic acid supplementary
Intervention Description
Various studies have revealed that folate is essential in early embryo development, whereas folate level evaluation in periconception women is not included in routine health cares. Therefore, we evaluate subject's folate level by serum and red blood cell folate examination. By combination of folate supplement obtained by questionnaire,folate level evaluated by examinations and folate metabolism ability evaluated by genotyping key enzymes in folate metabolism, an individualized folic acid supplementary guide is given to subjects. Red blood cell folate concentration >400 ng/ml before pregnancy is recommended.
Intervention Type
Procedure
Intervention Name(s)
Additional health care procedures during and after pregnancy
Other Intervention Name(s)
Green channels for antenatal care and postnatal care
Intervention Description
Fetus with birth defect will be referred to a tertiary hospital to receive genetic assessments and prenatal diagnosis to reduce unnecessary abortions. A 6-months follow up will be conducted to follow children's birth outcomes. It also helps clinical team to give early diagnosis and treatment for children with birth defect to reduce disability and improve life quality of defect children.
Primary Outcome Measure Information:
Title
Incidence of total fetal birth defects found during the second trimester, still birth, and neontal birth defects identified after delivery
Description
This is a composite outcome: the total number of fetus defects detected by Down's syndrome screenings, NT examinations and Ultrasound image examinations during the second trimester, stillbirth, and the number of birth defects after delivery diagnosed by clinical team. (Defects are classified in consistent with our birth defect monitoring policy, which have 24 types of defects: Anencephalus; Spina bifida; Encephalocele; Congenital Hydrocephalus; Cleft Palate; Cleft Lip; Cleft Lip with Cleft Palate; Microtia (including Anotia); Deformity of external ear(s) (except Microtia and Anotia); Esophageal atresia or stenosis; Anorectal atresia (including Congenital Anorectal Malformations); Hypospadia; Ectopocystis; Pes Equinovarus; Polydactylism; Syndactylia; Limb shortening; Congenital Diaphragmatic Hernia; Pcromphalus; Celoschisis; Conjoined Twins; Trisomy 21 syndrome; Congenital heart disease; Others. )
Time Frame
From the confirmation of pregnant to 28 days after birth
Secondary Outcome Measure Information:
Title
Incidence rate of total abortion because of the affected congenital defects
Description
Reasons of abortion are recorded
Time Frame
From the confirmation of pregnant to the 28th gestational week
Title
Incidence of death or severe organ dysfunctions
Description
Severe organ dysfunctions were defined based on specialty clinical examinaitons
Time Frame
From birth to 6 months after delivery ( can be expanding to the end of the 7th month)
Title
Extra medical cost that relates to affecting any birth defects during pregnancy and after birth
Description
Additional medical cost that exceeds normal pregnancies and children within one year old
Time Frame
From confirmation of pregnancy to one year old after birth
Title
incidence of congenital heart defect
Description
congenital heart defects diagnosed during pregnancy (ultrasound) and after birth( Echocardiography). (Definition see Zhao et al. Lancet 2014)
Time Frame
from conception to one year old
Title
Total pregnancy loss
Description
artificial abortions without any medical reasons were exluded
Time Frame
from conception to 28 gestational weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Females and their husbands attend pre-pregnancy physical examinations from Minhang distrit and Songjiang distrit in Shanghai. Couples who have planned to be pregnant within a year Women are between 18 and 45 years old Exclusion Criteria: -
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wei L Yan, Ph.D
Phone
86 21 64931215
Ext
86 21 64931215
Email
yanwl@fudan.edu.cn
First Name & Middle Initial & Last Name or Official Title & Degree
Ying G Huang, MD, Ph.D
Phone
86-21-64931928
Ext
86-21-64931913
Email
gyhuang@shmu.edu.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ying G Huang, MD, Ph.D
Organizational Affiliation
Children's Hospital of Fudan University
Official's Role
Study Chair
Facility Information:
Facility Name
Children Hospital of Fudan University
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
201102
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guoying Huang
Phone
(21)64931928
Email
gyhuang@shmu.edu.cn

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
27572879
Citation
Liu S, Joseph KS, Luo W, Leon JA, Lisonkova S, Van den Hof M, Evans J, Lim K, Little J, Sauve R, Kramer MS; Canadian Perinatal Surveillance System (Public Health Agency of Canada). Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes. Circulation. 2016 Aug 30;134(9):647-55. doi: 10.1161/CIRCULATIONAHA.116.022126.
Results Reference
background
PubMed Identifier
24284617
Citation
Czeizel AE, Dudas I, Vereczkey A, Banhidy F. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients. 2013 Nov 21;5(11):4760-75. doi: 10.3390/nu5114760.
Results Reference
background
PubMed Identifier
26140186
Citation
Ebadifar A, KhorramKhorshid HR, Kamali K, Salehi Zeinabadi M, Khoshbakht T, Ameli N. Maternal Supplementary Folate Intake, Methylenetetrahydrofolate Reductase (MTHFR) C677T and A1298C Polymorphisms and the Risk of Orofacial Cleft in Iranian Children. Avicenna J Med Biotechnol. 2015 Apr-Jun;7(2):80-4.
Results Reference
background
PubMed Identifier
32819312
Citation
Li M, Zhang Y, Chen X, Wang D, Ji M, Jiang Y, Dou Y, Ma X, Sheng W, Yan W, Huang G. Effectiveness of community-based folate-oriented tertiary interventions on incidence of fetus and birth defects: a protocol for a single-blind cluster randomized controlled trial. BMC Pregnancy Childbirth. 2020 Aug 20;20(1):475. doi: 10.1186/s12884-020-03154-w.
Results Reference
derived

Learn more about this trial

Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects

We'll reach out to this number within 24 hrs